Parr McKnight Wealth Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,371
Closed -$2.51M 218
2025
Q4
$2.51M Buy
26,371
+938
+4% +$92K 0.33% 95
2025
Q3
$2.48M Buy
25,433
+979
+4% +$101K 0.33% 97
2025
Q2
$2.63M Buy
24,454
+480
+2% +$48.6K 0.36% 91
2025
Q1
$2.42M Buy
23,974
+29
+0.1% +$2.92K 0.35% 94
2024
Q4
$2.14M Buy
+23,945
New +$2.11M 0.31% 94

Other funds holding BSX

Parr McKnight Wealth Management Group's BSX Position: Q1 2026 in Review

Parr McKnight Wealth Management Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 26,371 shares — an estimated $2.51M sold.

Parr McKnight Wealth Management Group first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $2.63M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Parr McKnight Wealth Management Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Parr McKnight Wealth Management Group sold 26,371 Boston Scientific shares in Q1 2026, an estimated $2.51M.
  • Parr McKnight Wealth Management Group first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • Parr McKnight Wealth Management Group's Boston Scientific position peaked at $2.63M in Q2 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.